Zobrazeno 1 - 10 of 23 pro vyhledávání: '"Yoshiyuki Hama"'
1
Akademický článek
PIONEER REAL Japan: Primary results from a multicenter, prospective, real‐world study of oral semaglutide in adults with type 2 diabetes in Japanese clinical practice
Autor: Daisuke Yabe, Yoshiyuki Hamamoto, Daiji Kawanami, Rimei Nishimura, Yasuo Terauchi, Hanan Amadid, Uffe Christian Braae, Atheline Major‐Pedersen, Ryo Suzuki
Publikováno v: Journal of Diabetes Investigation, Vol 15, Iss 11, Pp 1566-1577 (2024)
ABSTRACT Aims/Introduction PIONEER REAL Japan was a non‐interventional prospective study of oral semaglutide in adults with type 2 diabetes in Japanese clinical practice. Materials and Methods Adults naïve to injectable glucose‐lowering therapie
Externí odkaz: https://doaj.org/article/bee292befe0140b7b311e6794652d856
Zobrazit plný text záznamu
2
Akademický článek
Clinical lessons for diabetes treatment from the COVID‐19 pandemic
Autor: Yoshiyuki Hamamoto
Publikováno v: Journal of Diabetes Investigation, Vol 15, Iss 10, Pp 1363-1364 (2024)
In this paper, lessons from the reports about COVID‐19 from Japan are summarized.
Externí odkaz: https://doaj.org/article/8bdad78db1514d4da79b6d9ac14bae7a
Zobrazit plný text záznamu
5
Akademický článek
Stigma evaluation for diabetes and other chronic non‐communicable disease patients: Development, validation and clinical use of stigma scale – The Kanden Institute Stigma Scale
Autor: Nagaaki Tanaka, Yoshiyuki Hamamoto, Yuri Kurotobi, Yuji Yamazaki, Susumu Nakatani, Miho Matsubara, Takuya Haraguchi, Yuko Yamaguchi, Kiyohiro Izumi, Yuki Fujita, Hitoshi Kuwata, Takanori Hyo, Masaki Yanase, Masahiro Matsuda, Shinji Negoro, Hiroko Higashiyama, Yuichiro Yamada, Takeshi Kurose, Yutaka Seino
Publikováno v: Journal of Diabetes Investigation, Vol 13, Iss 12, Pp 2081-2090 (2022)
Abstract Aims/Introduction The aim of this study was to develop a scale to evaluate disease stigma in patients with lifestyle‐related chronic non‐communicable diseases (LCNCDs), which we named the Kanden Institute Stigma Scale (KISS), and to cons
Externí odkaz: https://doaj.org/article/30cab249e80249f8abafc1c7784394c6
Zobrazit plný text záznamu
9
Akademický článek
Effects of glucagon‐like peptide‐1 receptor agonists on secretions of insulin and glucagon and gastric emptying in Japanese individuals with type 2 diabetes: A prospective, observational study
Autor: Hitoshi Kuwata, Daisuke Yabe, Kenta Murotani, Yuuka Fujiwara, Takuya Haraguchi, Sodai Kubota, Saki Kubota‐Okamoto, Ryota Usui, Minori Ishitobi, Yuji Yamazaki, Yoshiyuki Hamamoto, Takeshi Kurose, Yusuke Seino, Yuichiro Yamada, Yutaka Seino
Publikováno v: Journal of Diabetes Investigation, Vol 12, Iss 12, Pp 2162-2171 (2021)
Abstract Aims/Introduction Differences in the glucose‐lowering mechanisms of glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) have been noted. Clarifying these differences could facilitate the choice of optimal drugs for individuals with
Externí odkaz: https://doaj.org/article/4f505952d52e4f2e91a68d483122f5de
Zobrazit plný text záznamu
10
Akademický článek
Lifestyle changes as a result of COVID‐19 containment measures: Bodyweight and glycemic control in patients with diabetes in the Japanese declaration of a state of emergency
Autor: Nagaaki Tanaka, Yoshiyuki Hamamoto, Yuri Kurotobi, Yuji Yamasaki, Susumu Nakatani, Miho Matsubara, Takuya Haraguchi, Yuko Yamaguchi, Kiyohiro Izumi, Yuki Fujita, Hitoshi Kuwata, Takanori Hyo, Yuichiro Yamada, Takeshi Kurose, Yutaka Seino
Publikováno v: Journal of Diabetes Investigation, Vol 12, Iss 9, Pp 1718-1722 (2021)
Abstract To clarify the association between lifestyle changes as a result of coronavirus disease 2019 containment measures and changes in metabolic and glycemic status in patients with diabetes, a cross‐sectional, single‐center, observation study
Externí odkaz: https://doaj.org/article/4a4afe341e764aefaa5a5b9a7b0b671c
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje